Drug Executive Collapses During Oval Office Press Conference
During a Thursday press conference in the Oval Office, a drug executive fainted while President Donald Trump announced a deal with pharmaceutical companies to lower obesity drug prices.
Press Conference Interrupted
The event, featuring President Trump and executives from Eli Lilly and Novo Nordisk, was focused on expanding coverage and reducing prices for obesity treatments Zepbound and Wegovy. As Eli Lilly CEO David Ricks spoke, he noticed a man nearby losing consciousness.
“Are you OK? Gordon, are you OK?” — David Ricks
Incident Details
The man who collapsed was identified as Gordon Findlay, global brand director for Novo Nordisk. Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, quickly assisted as Findlay fell to his knees and passed out. The press was then asked to leave the room.
Presence of Officials
- President Donald Trump was announcing the pricing deal.
- Mehmet Oz, CMS Administrator, intervened immediately.
- The Health and Human Services Secretary was also in the room.
"President Donald Trump looks on as Administrator for the Centers for Medicare & Medicaid Services Dr. Mehmet Oz and others help a man identified as Gordon Findlay, who passed out during an event where Trump made a statement on lowering drug price." — Getty Images description
The incident cut short the press event aimed at publicizing efforts to reduce the cost of key obesity medications.
Summary: A press conference was abruptly ended after Gordon Findlay, a Novo Nordisk executive, fainted during President Trump's announcement on lowering obesity drug prices, with CMS Administrator Mehmet Oz providing immediate aid.
Would you like the summary to be more formal or conversational?